PerkinElmer is working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and NGS library preparation solutions they need to rapidly respond to the SARS-CoV-2 challenges both today and tomorrow. To further understand the pathogenesis of viral infection and host immune responses, PerkinElmer's high throughput screening and imaging platforms are designed to enable the detection, characterization, visualization, and quantitation of virus and host biomarkers and associated workflows in therapeutics discovery and development. With flexible, single-source workflows, PerkinElmer is here to provide the technology and support you need.